News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Treatment Optimisation: Making Cancer Treatment Accessible and Sustainable in Europe – EORTC
EORTC/LinkedIn
Jul 1, 2025, 10:07

Treatment Optimisation: Making Cancer Treatment Accessible and Sustainable in Europe – EORTC

EORTC (European Organisation for Research and Treatment of Cancer) shared a post on LinkedIn:

“Event on Treatment Optimisation: Making Cancer Treatment Accessible and Sustainable in Europe.
Join us for an EORTC event at the European Parliament hosted by Mrs R. Jerkovic to discuss how treatment optimisation trials are key in guiding clinicians toward the most effective use of anti-cancer drugs.
Date: 25 September 2025
Held in: Brussels and Online
Register by 12 September.”

Registration.

Read further.

More posts featuring EORTC.

cancer EORTC European Organisation for Research and Treatment of Cancer OncoDaily Oncology Treatment Optimisation
Special Coverage
Science
Aug 13, 2025, 15:48
Myeloma Paper of the Day, August 13th, Suggested by Robert Orlowski
Insight
Aug 13, 2025, 15:36
Dora Vallejo-Ardila: Highlights from First Day of MOGA 2025
Voices
Aug 13, 2025, 15:34
Sameer Keole: Privilege of Being ASTRO President Is Meeting Talented People I’d Not Met Otherwise
Voices
Aug 13, 2025, 15:32
Diana Adams: Medical Oncology Group of Australia (MOGA)⁩ Session on Increasing Workforce Pressure
Voices
Aug 13, 2025, 15:30
Proud to be No.1 in Hypertension and No.6 in Cardiology Worldwide - Servier
Voices
Aug 13, 2025, 15:29
Stefano Magno: Integrative Oncology Teams to Bridge Oncology and Primary Care
Science
Aug 13, 2025, 15:26
Arndt Vogel: Interesting Analysis on Potential Biomarkers to Guide Adjuvant Treatment
Voices
Aug 13, 2025, 15:25
Yvonne Diaz: Survival Rates for the Deadliest Cancers
Insight
Aug 13, 2025, 15:20
Amol Akhade: KEYNOTE-905 - Potential Practice Changer in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Blog Posts
Aug 13, 2025, 15:18
Ryan Nipp: Patient-Reported Symptoms Linked to Emergency Care in Chemotherapy
Insight
Aug 13, 2025, 15:15
Stephen V Liu: Comparison of EGFR NSCLC Transformed to SCLC vs de novo SCLC
Insight
Aug 13, 2025, 15:14
New FDA PreCheck Program to Boost U.S. Drug Manufacturing